Cargando…
Anti-mesothelin vaccine CRS-207 with or without low-dose cyclophosphamide plus chemotherapy as front-line treatment for malignant pleural mesothelioma (MPM)
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645421/ http://dx.doi.org/10.1186/2051-1426-3-S2-P161 |
| _version_ | 1782400810155507712 |
|---|---|
| author | Hassan, Raffit Alley, Evan Kindler, Hedy Antonia, Scott Jahan, Thierry Thomas, Anish Honarmand, Somayeh Murphy, Aimee L Grous, John J Brockstedt, Dirk G |
| author_facet | Hassan, Raffit Alley, Evan Kindler, Hedy Antonia, Scott Jahan, Thierry Thomas, Anish Honarmand, Somayeh Murphy, Aimee L Grous, John J Brockstedt, Dirk G |
| author_sort | Hassan, Raffit |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4645421 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-46454212015-11-20 Anti-mesothelin vaccine CRS-207 with or without low-dose cyclophosphamide plus chemotherapy as front-line treatment for malignant pleural mesothelioma (MPM) Hassan, Raffit Alley, Evan Kindler, Hedy Antonia, Scott Jahan, Thierry Thomas, Anish Honarmand, Somayeh Murphy, Aimee L Grous, John J Brockstedt, Dirk G J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4645421/ http://dx.doi.org/10.1186/2051-1426-3-S2-P161 Text en Copyright © 2015 Hassan et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Hassan, Raffit Alley, Evan Kindler, Hedy Antonia, Scott Jahan, Thierry Thomas, Anish Honarmand, Somayeh Murphy, Aimee L Grous, John J Brockstedt, Dirk G Anti-mesothelin vaccine CRS-207 with or without low-dose cyclophosphamide plus chemotherapy as front-line treatment for malignant pleural mesothelioma (MPM) |
| title | Anti-mesothelin vaccine CRS-207 with or without low-dose cyclophosphamide plus chemotherapy as front-line treatment for malignant pleural mesothelioma (MPM) |
| title_full | Anti-mesothelin vaccine CRS-207 with or without low-dose cyclophosphamide plus chemotherapy as front-line treatment for malignant pleural mesothelioma (MPM) |
| title_fullStr | Anti-mesothelin vaccine CRS-207 with or without low-dose cyclophosphamide plus chemotherapy as front-line treatment for malignant pleural mesothelioma (MPM) |
| title_full_unstemmed | Anti-mesothelin vaccine CRS-207 with or without low-dose cyclophosphamide plus chemotherapy as front-line treatment for malignant pleural mesothelioma (MPM) |
| title_short | Anti-mesothelin vaccine CRS-207 with or without low-dose cyclophosphamide plus chemotherapy as front-line treatment for malignant pleural mesothelioma (MPM) |
| title_sort | anti-mesothelin vaccine crs-207 with or without low-dose cyclophosphamide plus chemotherapy as front-line treatment for malignant pleural mesothelioma (mpm) |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645421/ http://dx.doi.org/10.1186/2051-1426-3-S2-P161 |
| work_keys_str_mv | AT hassanraffit antimesothelinvaccinecrs207withorwithoutlowdosecyclophosphamidepluschemotherapyasfrontlinetreatmentformalignantpleuralmesotheliomampm AT alleyevan antimesothelinvaccinecrs207withorwithoutlowdosecyclophosphamidepluschemotherapyasfrontlinetreatmentformalignantpleuralmesotheliomampm AT kindlerhedy antimesothelinvaccinecrs207withorwithoutlowdosecyclophosphamidepluschemotherapyasfrontlinetreatmentformalignantpleuralmesotheliomampm AT antoniascott antimesothelinvaccinecrs207withorwithoutlowdosecyclophosphamidepluschemotherapyasfrontlinetreatmentformalignantpleuralmesotheliomampm AT jahanthierry antimesothelinvaccinecrs207withorwithoutlowdosecyclophosphamidepluschemotherapyasfrontlinetreatmentformalignantpleuralmesotheliomampm AT thomasanish antimesothelinvaccinecrs207withorwithoutlowdosecyclophosphamidepluschemotherapyasfrontlinetreatmentformalignantpleuralmesotheliomampm AT honarmandsomayeh antimesothelinvaccinecrs207withorwithoutlowdosecyclophosphamidepluschemotherapyasfrontlinetreatmentformalignantpleuralmesotheliomampm AT murphyaimeel antimesothelinvaccinecrs207withorwithoutlowdosecyclophosphamidepluschemotherapyasfrontlinetreatmentformalignantpleuralmesotheliomampm AT grousjohnj antimesothelinvaccinecrs207withorwithoutlowdosecyclophosphamidepluschemotherapyasfrontlinetreatmentformalignantpleuralmesotheliomampm AT brockstedtdirkg antimesothelinvaccinecrs207withorwithoutlowdosecyclophosphamidepluschemotherapyasfrontlinetreatmentformalignantpleuralmesotheliomampm |